Latest News

Brian M. Slomovitz, M.D.

Brian M. Slomovitz, M.D.

Combination Drug Therapy Shows Promise for Recurrent Endometrial Cancer

Researchers seeking to improve treatment outcomes for women with recurrent endometrial cancer – the most commonly diagnosed gynecologic malignancy in the U.S., killing more than 8,000 women each year – have reported positive results through targeted therapy that uses a combination of the drugs everolimus and letrozole. Their findings have been reported in the Journal of Clinical Oncology.

“Recurrent endometrial cancer is very difficult to treat,” said Brian M. Slomovitz, M.D., professor of clinical obstetrics and gynecology, Director of Gynecologic Oncology and lead author of the article, who conducted the research with colleagues at MD Anderson Cancer Center in Houston before joining the Miller School of Medicine’s Sylvester Comprehensive Cancer Center last August. “It’s rare to get a good response to conventional chemotherapy after the first round. We needed to look for other options that would provide the best possible response right from the start.”

Read more about Dr. Slomovitz's research »

More News

Abdulla Damluji, M.D.

Researchers Find Association between Inflammatory States and Early Development of Atherosclerosis

A multidisciplinary group of Miller School of Medicine researchers has identified an important association between baseline inflammatory states in asymptomatic patients and early development of coronary artery disease. The results have been published in the Online First edition of Heart: British Medical Journal as “Association between Anti-Human Shock Protein-60 and Interleukin-2 (IL-2) with Coronary Artery Calcium Score.”

Read more about the research »

From left, Emmanuelle Simonet, M.A., CCRP, Jacqueline Reyes, Administrative Assistant, Pulmonary Lab at UMHC, Shirin Shafazand, M.D., Marilyn Glassberg, M.D., Patricia Rebolledo, Research Assistant, Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, and Francisco Padron, RCP, RPFT, Pulmonary Lab at UMHC.

Miller School Selected for National Pulmonary Fibrosis Foundation Care Center Network

The University of Miami Miller School of Medicine has been selected as a member of the Pulmonary Fibrosis Foundation Care Center Network and Patient Registry, a designation that will significantly enhance the clinical care provided to patients at UHealth – University of Miami Health System.

Read more about the network membership »

Dean Pascal J. Goldschmidt, M.D., and Sebastian the Ibis. Video & Photo Gallery

Students Host Another Successful DOCS Dean’s 5K Walk/Run

The Third Annual DOCS Dean’s 5K Walk/Run attracted more than 100 participants and raised nearly $5,000. The event, organized by Miller School of Medicine students, raises awareness and funds for the Mitchell Wolfson Sr. Department of Community Service (DOCS) to help buy supplies and equipment.

Read more about this year's DOCS Dean 5K Walk/Run »

Alberto Pugliese, M.D.

Diabetes Researcher Honored by JDRF

Alberto Pugliese, M.D., head of the Immunogenetics Program at the Diabetes Research Institute at the University of Miami Miller School of Medicine, has accepted the JDRF Mary Tyler Moore and S. Robert Levine Excellence in Clinical Research Award on behalf of the JDRF Network for Pancreatic Organ Donors with Diabetes (nPOD).

Read more about the award »

Wendy Epley, center, with Special Agents Kevin Parker and Tina Stasulli Korb.

International Travel Workshop Promotes Safety of Faculty, Staff and Students

The Office of Export Control & Technology Management hosted the first International Travel Workshop on the Miller School of Medicine, Coral Gables and Rosenstiel campuses January 15-16 to help faculty, staff and students not only understand the University processes involved with international travel, but also be able to identify risks associated with travel.

Read more about the workshop »

News & Events »

Office of the Dean

A message from the dean


Read Med


Read e-Update